← FDA Drug Approvals (Drugs@FDA)

DECITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2019-09-16

Drug application

FDA Application #

ANDA210984

Application type

Abbreviated New Drug Application (Generic)

Brand name

DECITABINE

Generic name

DECITABINE

Active ingredients

DECITABINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

NOVAST LABS

Manufacturer

BluePoint Laboratories

First approval

2019-09-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown